KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Liabilities (2019 - 2025)

GoodRx Holdings' Total Liabilities history spans 7 years, with the latest figure at -$616.3 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 192.89% year-over-year to -$616.3 million; the TTM value through Dec 2025 reached -$616.3 million, down 192.89%, while the annual FY2025 figure was -$616.3 million, 192.89% down from the prior year.
  • Total Liabilities for Q4 2025 was -$616.3 million at GoodRx Holdings, down from $724.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $826.8 million in Q4 2023 and bottomed at -$616.3 million in Q4 2025.
  • The 5-year median for Total Liabilities is $771.0 million (2021), against an average of $688.6 million.
  • The largest YoY upside for Total Liabilities was 10.08% in 2025 against a maximum downside of 192.89% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $775.9 million in 2021, then increased by 1.79% to $789.8 million in 2022, then rose by 4.69% to $826.8 million in 2023, then dropped by 19.77% to $663.4 million in 2024, then plummeted by 192.89% to -$616.3 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Total Liabilities are -$616.3 million (Q4 2025), $724.8 million (Q3 2025), and $675.7 million (Q2 2025).